業績

2016年

  1. Masakane I, Hasegawa T, Ogata S, Kimata N, Nakai S, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. Peritoneal Dialysis Registry With 2013 Survey Report.Ther Apher Dial. 2016 Dec;20(6):557-568.
  2. Sato M, Takei T, Moriyama T, Itabashi M, Nitta K. Long-term outcomes of initial therapy for idiopathic membranous nephropathy. Clin Exp Nephrol. 2016 Dec 20. doi: 10.1007/s10157-016-1371-8. [Epub ahead of print]
  3. Kamei D, Tsuchiya K, Miura H, Nitta K, Akiba T. Inter-Method Variability of Ferritin and Transferrin Saturation Measurement Methods in Patients on Hemodialysis. Ther Apher Dial. 2017 Feb;21(1):43-51.
  4. Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A; CKD-JAC Investigators. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017 Jan;91(1):227-234.
  5. Hirose O, Itabashi M, Takei T, Honda K, Nitta K. Antineutrophil cytoplasmic antibody-associated glomerulonephritis with immunoglobulin deposition. Clin Exp Nephrol. 2016 Nov 9. [Epub ahead of print]
  6. Unagami K, Ishida H, Okumi M, Hirai T, Toki D, Omoto K, Shimizu T, Inui M, Nitta K, Tanabe K.　Assessment of 4 Cases of Kidney Transplantation from Hepatitis C Virus　Antibody-Positive and RNA-Negative Donors to Antibody-Negative Recipients. Transplant Direct. 2016 Aug 26;2(9):e102.
  7. Momoki K, Kataoka H, Moriyama T, Mochizuki T, Nitta K. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. J Atheroscler Thromb. 2016 Oct 26. [Epub ahead of print]
  8. Nishida M, Ando M, Iwamoto Y, Tsuchiya K, Nitta K. New Insight into Atherosclerosis in Hemodialysis Patients: Overexpression of Scavenger Receptor and Macrophage Colony-Stimulating Factor Genes. Nephron Extra. 2016 Aug 27;6(2):22-30.
  9. Momoki K, Yamaguchi T, Ohashi K, Ando M, Nitta K. Emergence of Dipstick Proteinuria Predicts Overt Nephropathy in Patients Following Stem Cell Transplantation. Nephron. 2017;135(1):31-38.
  10. Naito T, Sanaka T, Mikami H, Soga A, Yamatani K, Segawa K, Kawashima M, Yoshikura T, Niwayama J, Nishimura H, Ogawa T, Ando A, Teramoto A, Nitta K.　Modulation of circulating endothelial progenitor cells by erythropoiesis-stimulating agents in patients with chronic kidney disease stage G5 and 5D?.　Clin Nephrol. 2016 Nov;86 (2016)(11):242-252.
  11. Tokoroyama T, Ando M, Setoguchi K, Tsuchiya K, Nitta K.Prevalence, incidence and prognosis of chronic kidney disease classified according to current guidelines: a large retrospective cohort study of rheumatoid arthritis patients. Nephrol Dial Transplant. 2016 Sep 16. pii: gfw315. [Epub ahead of print]
  12. Hoshino Y, Moriyama T, Uchida K, Tsuchiya K, Nitta K. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
  13. Akiyama K, Mochizuki T, Kataoka H, Tsuchiya K, Nitta K. Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease.　Nephrology (Carlton). 2016 Jul 23. doi: 10.1111/nep.12862. [Epub ahead of print]
  14. Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Hishida A; Chronic Kidney Disease Japan Cohort Study Group. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study. Clin Exp Nephrol. 2016 Jul 13. [Epub ahead of print]
  15. Yajima A, Tsuchiya K, Yokota H, Nitta K. [Bone disease in the field of CKD-MBD].　Clin Calcium. 2016 Jun;26(6):875-80. Japanese.
  16. Hara M, Yanagisawa N, Ohta A, Momoki K, Tsuchiya K, Nitta K, Ando M. Increased non-HDL-C level linked with a rapid rate of renal function decline in HIV-infected patients. Clin Exp Nephrol. 2016 May 18. [Epub ahead of print]
  17. Ubukata M, Amemiya N, Nitta K, Takei T. Serum Thiamine Values in End-Stage Renal Disease Patients under Maintenance Hemodialysis. Int J Vitam Nutr Res. 2016
  18. Iwasaki C, Moriyama T, Tanaka K, Takei T, Nitta K. Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria. J Nephropathol. 2016 Apr;5(2):72-8.
  19. Sawada A, Kawanishi K, Horita S, Koike J, Honda K, Ochi A, Komoda M, Tanaka Y, Unagami K, Okumi M, Shimizu T, Ishida H, Tanabe K, Nagashima Y, Nitta K. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft. Nephrology (Carlton). 2016 Jul;21 Suppl 1:48-52.
  20. Miyaoka T, Itabashi M, Kumon S, Akiyama K, Iwabuchi Y, Kataoka H, Moriyama T, Takei T, Nitta K. [Rituximab therapy in the treatment of anti-neutrophil cytoplasmic antibody (ANCA) -positive interstitial pneumonia: case report].　Nihon Jinzo Gakkai Shi. 2016;58(1):38-44. Japanese.
  21. Okubo Y, Matsushita S, Takakuwa Y, Yoshioka T, Nitta K. Longitudinal PBL in Undergraduate Medical Education Develops Lifelong-Learning Habits and Clinical Competencies in Social Aspects. Tohoku J Exp Med. 2016;238(2):185.
  22. Kataoka H, Ariyama Y, Deushi M, Osaka M, Nitta K, Yoshida M. Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro.　PLoS One. 2016 Jan 29;11(1):e0147929.
  23. Unagami K, Nitta K, Tago K, Matsushita K. Relationship Between Diastolic　Dysfunction and Atherosclerosis and Vascular Calcification in Hemodialysis Patients: Diagnostic Potential of the Cardio-Ankle Vascular Index. Ther Apher Dial. 2016 Apr;20(2):135-41.
  24. Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013). Ther Apher Dial. 2015 Dec;19(6):540-74.
  25. Okubo Y, Matsushita S, Takakuwa Y, Yoshioka T, Nitta K. Longitudinal PBL in Undergraduate Medical Education Develops Lifelong-Learning Habits and Clinical Competencies in Social Aspects. Tohoku J Exp Med. 2016;238(1):65-74.
  26. Shiohira S, Komatsu M, Okazaki M, Naganuma T, Kawaguchi H, Nitta K, Tsuchiya K.　Effect of Taurine on Hemodiafiltration in Patients With Chronic Heart Failure. Ther　Apher Dial. 2016 Feb;20(1):20-6.
  27. Ubukata M, Takei T, Nitta K. Estimation of the 24-h urinary protein excretion based on the estimated urinary creatinine output. Clin Exp Nephrol. 2016 Jun;20(3):456-61.
  28. Nishizawa Y, Takei T, Miyaoka T, Kamei D, Mochizuki T, Nitta K. Alport syndrome and pregnancy: Good obstetric and nephrological outcomes in a pregnant woman with homozygous autosomal recessive Alport syndrome.　J Obstet Gynaecol Res. 2016 Mar;42(3):331-5.